systems biology laboratory uk c.i.c
systems biology laboratory uk c.i.c Company Information
Company Number
05128153
Website
http://sbl-uk.orgRegistered Address
unit 7 127 milton park, milton, abingdon, oxfordshire, OX14 4SA
Industry
Other research and experimental development on natural sciences and engineering
Telephone
01235827400
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
fischer medical project ltd 100%
systems biology laboratory uk c.i.c Estimated Valuation
Pomanda estimates the enterprise value of SYSTEMS BIOLOGY LABORATORY UK C.I.C at £334.3k based on a Turnover of £384.4k and 0.87x industry multiple (adjusted for size and gross margin).
systems biology laboratory uk c.i.c Estimated Valuation
Pomanda estimates the enterprise value of SYSTEMS BIOLOGY LABORATORY UK C.I.C at £8.9m based on an EBITDA of £2.1m and a 4.18x industry multiple (adjusted for size and gross margin).
systems biology laboratory uk c.i.c Estimated Valuation
Pomanda estimates the enterprise value of SYSTEMS BIOLOGY LABORATORY UK C.I.C at £0 based on Net Assets of £-3.1m and 2.25x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Systems Biology Laboratory Uk C.i.c Overview
Systems Biology Laboratory Uk C.i.c is a live company located in abingdon, OX14 4SA with a Companies House number of 05128153. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in May 2004, it's largest shareholder is fischer medical project ltd with a 100% stake. Systems Biology Laboratory Uk C.i.c is a mature, micro sized company, Pomanda has estimated its turnover at £384.4k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Systems Biology Laboratory Uk C.i.c Health Check
Pomanda's financial health check has awarded Systems Biology Laboratory Uk C.I.C a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
5 Weak
Size
annual sales of £384.4k, make it smaller than the average company (£4.4m)
- Systems Biology Laboratory Uk C.i.c
£4.4m - Industry AVG
Growth
3 year (CAGR) sales growth of -17%, show it is growing at a slower rate (3.9%)
- Systems Biology Laboratory Uk C.i.c
3.9% - Industry AVG
Production
with a gross margin of 47%, this company has a comparable cost of product (47%)
- Systems Biology Laboratory Uk C.i.c
47% - Industry AVG
Profitability
an operating margin of 542.5% make it more profitable than the average company (4.8%)
- Systems Biology Laboratory Uk C.i.c
4.8% - Industry AVG
Employees
with 8 employees, this is below the industry average (47)
8 - Systems Biology Laboratory Uk C.i.c
47 - Industry AVG
Pay Structure
on an average salary of £61.6k, the company has an equivalent pay structure (£61.6k)
- Systems Biology Laboratory Uk C.i.c
£61.6k - Industry AVG
Efficiency
resulting in sales per employee of £48k, this is less efficient (£108.4k)
- Systems Biology Laboratory Uk C.i.c
£108.4k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (53 days)
- Systems Biology Laboratory Uk C.i.c
53 days - Industry AVG
Creditor Days
its suppliers are paid after 50 days, this is close to average (47 days)
- Systems Biology Laboratory Uk C.i.c
47 days - Industry AVG
Stock Days
it holds stock equivalent to 53 days, this is less than average (111 days)
- Systems Biology Laboratory Uk C.i.c
111 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 128 weeks, this is more cash available to meet short term requirements (36 weeks)
128 weeks - Systems Biology Laboratory Uk C.i.c
36 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 256.2%, this is a higher level of debt than the average (44.2%)
256.2% - Systems Biology Laboratory Uk C.i.c
44.2% - Industry AVG
SYSTEMS BIOLOGY LABORATORY UK C.I.C financials
Systems Biology Laboratory Uk C.I.C's latest turnover from December 2022 is estimated at £384.4 thousand and the company has net assets of -£3.1 million. According to their latest financial statements, Systems Biology Laboratory Uk C.I.C has 8 employees and maintains cash reserves of £1.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 926,996 | 1,544,536 | 668,735 | 627,258 | 694,750 | |||||||||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | |||||||||
| Cost Of Sales | 471,481 | 1,084,075 | 436,741 | 415,759 | 442,276 | |||||||||
| Gross Profit | 455,515 | 460,461 | 231,994 | 211,499 | 252,474 | |||||||||
| Admin Expenses | 307,140 | 349,773 | 243,253 | 167,072 | 170,781 | |||||||||
| Operating Profit | 148,375 | 110,688 | -11,259 | 44,427 | 81,693 | |||||||||
| Interest Payable | 13,445 | 16,057 | 27,516 | 24,306 | 17,427 | |||||||||
| Interest Receivable | 1 | 5 | 24 | 91 | 123 | |||||||||
| Pre-Tax Profit | 134,931 | 94,636 | -38,751 | 20,212 | 64,389 | |||||||||
| Tax | 47,328 | 45,508 | 24,898 | 0 | 0 | |||||||||
| Profit After Tax | 182,259 | 140,144 | -13,853 | 20,212 | 64,389 | |||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | |||||||||
| Retained Profit | 182,259 | 140,144 | -13,853 | 20,212 | 64,389 | |||||||||
| Employee Costs | ||||||||||||||
| Number Of Employees | 8 | 6 | 6 | 5 | 5 | 4 | 4 | |||||||
| EBITDA* | 180,603 | 134,080 | 8,541 | 64,773 | 97,277 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 195,525 | 223,631 | 64,628 | 44,252 | 58,366 | 72,411 | 32,778 | 38,944 | 87,239 | 155,589 | 227,868 | 317,700 | 344,453 | 399,549 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 100,000 | 100,000 | 100,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 295,525 | 323,631 | 164,628 | 44,252 | 58,366 | 72,411 | 32,778 | 38,944 | 87,239 | 155,589 | 227,868 | 317,700 | 344,453 | 399,549 |
| Stock & work in progress | 29,826 | 26,146 | 30,964 | 26,561 | 25,349 | 19,954 | 22,086 | 19,863 | 18,564 | 22,562 | 25,959 | 25,466 | 23,605 | 27,604 |
| Trade Debtors | 13 | 172 | 9,516,233 | 6,864 | 11,414 | 6,849 | 6,615 | 6,304 | 126,242 | 60,902 | 57,928 | 63,277 | 155,134 | 319,154 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 212,124 | 112,752 | 120,219 | 110,300 | 150,955 | 107,254 | 113,536 | 96,211 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1,423,298 | 120,742 | 159,921 | 60,632 | 18,671 | 48,759 | 21,160 | 121,822 | 129,616 | 93,777 | 98,871 | 165,913 | 35,243 | 66,050 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,665,261 | 259,812 | 9,827,337 | 204,357 | 206,389 | 182,816 | 163,397 | 244,200 | 274,422 | 177,241 | 182,758 | 254,656 | 213,982 | 412,808 |
| total assets | 1,960,786 | 583,443 | 9,991,965 | 248,609 | 264,755 | 255,227 | 196,175 | 283,144 | 361,661 | 332,830 | 410,626 | 572,356 | 558,435 | 812,357 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 28,380 | 16,041 | 9,506,253 | 9,990 | 14,703 | 14,046 | 14,939 | 14,650 | 594,806 | 566,530 | 583,547 | 694,060 | 817,251 | 793,161 |
| Group/Directors Accounts | 525,316 | 525,316 | 526,417 | 527,609 | 527,609 | 527,150 | 526,692 | 527,150 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 23,651 | 27,595 | 127,063 | 18,922 | 16,502 | 28,302 | 33,204 | 33,700 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 577,347 | 568,952 | 10,159,733 | 556,521 | 558,814 | 569,498 | 574,835 | 575,500 | 594,806 | 566,530 | 583,547 | 694,060 | 817,251 | 793,161 |
| loans | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 2,201,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 2,245,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 | 4,446,300 |
| total liabilities | 5,023,647 | 5,015,252 | 14,606,033 | 5,002,821 | 5,005,114 | 5,015,798 | 5,021,135 | 5,021,800 | 5,041,106 | 5,012,830 | 5,029,847 | 5,140,360 | 5,263,551 | 5,239,461 |
| net assets | -3,062,861 | -4,431,809 | -4,614,068 | -4,754,212 | -4,740,359 | -4,760,571 | -4,824,960 | -4,738,656 | -4,679,445 | -4,680,000 | -4,619,221 | -4,568,004 | -4,705,116 | -4,427,104 |
| total shareholders funds | -3,062,861 | -4,431,809 | -4,614,068 | -4,754,212 | -4,740,359 | -4,760,571 | -4,824,960 | -4,738,656 | -4,679,445 | -4,680,000 | -4,619,221 | -4,568,004 | -4,705,116 | -4,427,104 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 148,375 | 110,688 | -11,259 | 44,427 | 81,693 | |||||||||
| Depreciation | 38,720 | 32,228 | 23,392 | 19,800 | 20,346 | 15,584 | 21,421 | 48,553 | 89,314 | 96,876 | 95,621 | 95,082 | 105,394 | 131,118 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 47,328 | 45,508 | 24,898 | 0 | 0 | |||||||||
| Stock | 3,680 | -4,818 | 4,403 | 1,212 | 5,395 | -2,132 | 2,223 | 1,299 | -3,998 | -3,397 | 493 | 1,861 | -3,999 | 27,604 |
| Debtors | 99,213 | -9,523,528 | 9,519,288 | -45,205 | 48,266 | -6,048 | 17,636 | -23,727 | 65,340 | 2,974 | -5,349 | -91,857 | -164,020 | 319,154 |
| Creditors | 12,339 | -9,490,212 | 9,496,263 | -4,713 | 657 | -893 | 289 | -580,156 | 28,276 | -17,017 | -110,513 | -123,191 | 24,090 | 793,161 |
| Accruals and Deferred Income | -3,944 | -99,468 | 108,141 | 2,420 | -11,800 | -4,902 | -496 | 33,700 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 166,597 | 260,301 | 75,139 | -31 | 99,662 | |||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 100,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | -1,101 | -1,192 | 0 | 459 | 458 | -458 | 527,150 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 2,245,000 | -2,245,000 | 0 | 0 | 0 | 0 | 0 | 0 | 4,446,300 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | -2,245,000 | 2,245,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | -13,444 | -16,052 | -27,492 | -24,215 | -17,304 | |||||||||
| cash flow from financing | -14,545 | -17,244 | -27,492 | -23,756 | -16,846 | |||||||||
| cash and cash equivalents | ||||||||||||||
| cash | 1,302,556 | -39,179 | 99,289 | 41,961 | -30,088 | 27,599 | -100,662 | -7,794 | 35,839 | -5,094 | -67,042 | 130,670 | -30,807 | 66,050 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 1,302,556 | -39,179 | 99,289 | 41,961 | -30,088 | 27,599 | -100,662 | -7,794 | 35,839 | -5,094 | -67,042 | 130,670 | -30,807 | 66,050 |
systems biology laboratory uk c.i.c Credit Report and Business Information
Systems Biology Laboratory Uk C.i.c Competitor Analysis
Perform a competitor analysis for systems biology laboratory uk c.i.c by selecting its closest rivals and benchmarking them against 12 key performance metrics.
systems biology laboratory uk c.i.c Ownership
SYSTEMS BIOLOGY LABORATORY UK C.I.C group structure
Systems Biology Laboratory Uk C.I.C has no subsidiary companies.
Ultimate parent company
1 parent
SYSTEMS BIOLOGY LABORATORY UK C.I.C
05128153
systems biology laboratory uk c.i.c directors
Systems Biology Laboratory Uk C.I.C currently has 2 directors. The longest serving directors include Mr Michael Fischer (Jul 2004) and Mr Kenneth Brooks (Jan 2007).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Michael Fischer | 74 years | Jul 2004 | - | Director | |
| Mr Kenneth Brooks | 68 years | Jan 2007 | - | Director |
P&L
December 2022turnover
384.4k
-59%
operating profit
2.1m
0%
gross margin
47%
-4.42%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
-3.1m
-0.31%
total assets
2m
+2.36%
cash
1.4m
+10.79%
net assets
Total assets minus all liabilities
Similar Companies
systems biology laboratory uk c.i.c company details
company number
05128153
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
incorporation date
May 2004
age
20
accounts
Total Exemption Full
ultimate parent company
previous names
systems biology laboratory uk limited (January 2008)
ribostem limited (January 2007)
incorporated
UK
address
unit 7 127 milton park, milton, abingdon, oxfordshire, OX14 4SA
last accounts submitted
December 2022
systems biology laboratory uk c.i.c Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to systems biology laboratory uk c.i.c.
systems biology laboratory uk c.i.c Companies House Filings - See Documents
| date | description | view/download |
|---|
